Read + Share
Ao W, Kim HI, Tommarello D, Conrads KA, et al. Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to
loss of CDC25A expression and resistance to ATRi treatment. Gynecol Oncol 2023;177:60-71.
PMID: 37639904
|
 |
|
Ao W, Kim HI, Tommarello D, Conrads KA, et al. Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to
loss of CDC25A expression and resistance to ATRi treatment. Gynecol Oncol 2023;177:60-71.
PMID: 37639904
|
|
|
|